| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 3 239-250, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
J Marthinuss, L Lawrence and M Seiberg
Skin Biology Research Center, R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869, USA.
Programmed cell death is a controlled process that leads to the elimination of single cells via apoptosis, a mode of cell death with a characteristic morphology. During epidermal differentiation, keratinocytes migrate outward to become terminally differentiated cornified cells in a process involving programmed cell death pathway(s) and apoptosis. The molecular mechanisms regulating epidermal differentiation and apoptosis have not yet been elucidated. Here we show that a mouse keratinocyte cell line, Pam212, undergoes spontaneous apoptosis in culture. Apoptosis of Pam212 cells is demonstrated by both morphology and DNA oligonucleosomal degradation. The expression of bcl-2, a gene implicated in the negative control of apoptosis, was down-regulated in these cells by transfecting a bcl-2-antisense expression vector. The cells that down-regulate bcl-2 expression exhibit enhanced apoptosis and further progress in the epidermal differentiation pathway. We analyzed the expression patterns of several genes that have been implicated in apoptosis in other systems. We show that the mRNA levels of c-myc, c-myb, c-fos, tumor necrosis factors (TNF) alpha and beta, TNF receptors I and II, interleukin 1 alpha, IFN-gamma, and transforming growth factor beta increase in the antisense-transfected cells. We suggest that bcl-2 influences epidermal differentiation in Pam212 keratinocyte cells, and maybe in vivo, by negatively regulating several genes that are involved in apoptosis.
This article has been cited by other articles:
![]() |
J. Webster-Cyriaque, J. Middeldorp, and N. Raab-Traub Hairy Leukoplakia: an Unusual Combination of Transforming and Permissive Epstein-Barr Virus Infections J. Virol., August 15, 2000; 74(16): 7610 - 7618. [Abstract] [Full Text] |
||||
![]() |
C. W. Dawson, J. Dawson, R. Jones, K. Ward, and L. S. Young Functional Differences between BHRF1, the Epstein-Barr Virus-Encoded Bcl-2 Homologue, and Bcl-2 in Human Epithelial Cells J. Virol., November 1, 1998; 72(11): 9016 - 9024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kocikova, A. Kolesaric, F. Koszik, G. Stingl, and A. Elbe-Burger Murine Langerhans Cells Cultured Under Serum-Free Conditions Mature into Potent Stimulators of Primary Immune Responses In Vitro and In Vivo J. Immunol., October 15, 1998; 161(8): 4033 - 4041. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mehlen, A. Mehlen, J. Godet, and A.-P. Arrigo hsp27 as a Switch between Differentiation and Apoptosis in Murine Embryonic Stem Cells J. Biol. Chem., December 12, 1997; 272(50): 31657 - 31665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hines and B. L. Allen-Hoffmann Keratinocyte Growth Factor Inhibits Cross-linked Envelope Formation and Nucleosomal Fragmentation in Cultured Human Keratinocytes J. Biol. Chem., March 15, 1996; 271(11): 6245 - 6251. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |